Menu
Close
Olpha is ready to engage in pharmaceutical contract manufacturing to help your company achieve its strategic goals by offering our production plant and expertise.
Contact us
Formulation development and optimisation (for tablets, capsules, sachets)
Production of scalable series, i.e. from pilot series to validation series.
Execution of drug and excipient compatibility studies
Delivery of the developed technology to production
production
production capacity for tablets and capsules per year
investment in R&D in 2022
investment in new generic medicine portfolio in 2024
With a team of 800+ professional employees and 50+ years of experience, Olpha is an expert in the development and production of finished dosage forms and active pharmaceutical ingredients and intermediates in a vast range of therapeutic areas.
Olpha offers a competitive remuneration that complies with the industry standards and the employee’s professional experience, expertise, competences and input to promoting the growth of the enterprise. We also provide privileges and bonuses as well as celebrate outstanding and long–term employees by organising an employee awards event yealy.
We approach each client’s needs and evaluate each cooperation on an individual level. We believe the best way of collaborating is finding the most suitable solution for any need together.
Olpha is develops generics as well as APIs and stands out with the full-cycle production offering.
Olpha ensures consistent product availability to meet the market demand.
Efficient production processes, lower labour costs and regionally developed logistics result in greater cost efficiency.
Olpha holds its production to the highest industry quality standards. See more information on quality control and assurance on our Product governance page.
Our processes include effective sustainability measures, ensuring that our business processes are good for people and the planet. See more information on our Sustainability section.